HOFSETH BIOCARE ASA financial statements, including revenue, expenses, profit, and loss

The total revenue of HBCO for the last quarter is 45.89 M NOK, and it's 7.53% lower compared to the previous quarter. The net income of Q4 23 is -51.89 M NOK.